Navigation Links
Childhood virus RSV shows promise against adult cancer
Date:9/6/2012

SAN ANTONIO (Sept. 6, 2012) RSV, a virus that causes respiratory infections in infants and young children, selectively kills cancer cells while leaving healthy cells alone, researchers from the School of Medicine at The University of Texas Health Science Center San Antonio said.

Santanu Bose, Ph.D., of the School of Medicine, is the inventor on a pending U.S. patent of RSV as an oncolytic therapy. This represents a new use for the virus. Bandana Chatterjee, Ph.D., of the School of Medicine and the South Texas Veterans Health Care System, is the co-inventor. Oncolytic viruses preferentially infect and damage cancer cells.

Confirmed in mice

Dr. Bose, associate professor of microbiology and immunology, studied the immune response of normal and cancerous cells to RSV (respiratory syncytial virus). During these studies he discovered RSV's oncolytic properties. Dr. Bose next worked with Dr. Chatterjee, professor of molecular medicine, to test RSV in her mouse model of prostate cancer. Those results again showed a robust anti-cancer effect of RSV.

License agreement

In July, CZ BioMed Corp. of Tampa, Fla., licensed the oncolytic use of RSV in an agreement with South Texas Technology Management (STTM), a regional University of Texas technology-transfer office managed by the Health Science Center. RSV is already showing effectiveness in human trials abroad, according to a company statement.

Dr. Bose, whose work is funded by the National Institutes of Health, said, "This is an exciting development because this is a homegrown invention that is being tested in humans, and therefore this scientific discovery has direct clinical, translational relevance."

"We are pleased that CZ BioMed has agreed to work with us to commercialize Dr. Bose's and Dr. Chatterjee's exciting discovery to efficiently target and treat different forms of cancer," said STTM Executive Director Arjun Sanga, J.D., assistant vice president for technology transfer at the UT Health Science Center.

Advantages to therapy

Dr. Chatterjee said it is important that the virus killed tumors even in mice with competent immune systems. This mirrors human patients who have functioning immune defenses. RSV also worked whether it was injected directly into the tumor or systemically through the abdomen. "This is important because there are some tumors to which you can inject the drug directly, whereas others you can't and a drug must work systemically," Dr. Chatterjee said.

Her work on the RSV project is funded by a Merit-Review grant from the U.S. Department of Veterans Affairs (VA), a VA Senior Research Career Scientist Award, and a grant to Drs. Bose and Chatterjee from the National Cancer Institute.

Normal cells shoot down RSV, cancer cells can't

RSV is expected to be safe because it is a children's virus it does not infect adults. It also only infects the lungs. Dr. Bose explained why RSV grows only in tumors, not healthy cells: "It is because of the immune response. Normal cells have weapons to shoot down viruses, but cancer cells have lost their anti-viral arsenal. For this reason viruses can establish themselves in a tumor, grow and induce cell death."

Results in humans

A press release from CZ BioMed notes: "Ultimately, the results from human trials overseas have been extremely successful and exciting to date, with minimal side effects as compared to traditional chemo or radiation therapies." The company's statement also indicates its plan to conduct a clinical trial with oncolytic RSV in the U.S.

In a series of papers between 2009 and 2011, Drs. Bose, Chatterjee and colleagues advanced the RSV anti-cancer construct. The animal results were particularly exciting mice with prostate tumors were treated with the virus and within a week the tumors were gone. "We kept the mice for four months, and the tumors never came back," Dr. Bose said.


'/>"/>

Contact: Will Sansom
sansom@uthscsa.edu
210-567-2579
University of Texas Health Science Center at San Antonio
Source:Eurekalert  

Related medicine news :

1. Childhood sexual abuse linked to later heart attacks in men
2. Prenatal exposure to pesticide additive linked with childhood cough
3. Traumatic childhood may increase the risk of drug addiction
4. A breath of fresh air: Childhood Asthma Leadership Coalition launches
5. Radiation for Childhood Cancer Might Raise Diabetes Risk
6. Childhood Music Lessons May Create Better Listeners
7. Doing the math to fight childhood obesity
8. Existing drugs offer new treatment options for high-risk childhood leukemia subtype
9. Childhood Friendships May Be Key to Adult Happiness
10. Childhood defiance correlated with drug dependence
11. In-utero exposure to magnetic fields associated with increased risk of obesity in childhood
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Childhood virus RSV shows promise against adult cancer
(Date:1/20/2017)... Viejo, California (PRWEB) , ... January 20, 2017 , ... ... easy to use inside of Final Cut Pro X," said Christina Austin - CEO ... on the RED Dragon. Utilizing the Dragon Sensor,TransFlare 4K Mystique lens flare and light ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Mary Magdalene: Grace is Greater than ... the woman who witnessed Jesus Christ firsthand. “Mary Magdalene: Grace is Greater than Sin” ... career as an educator interacting with countless women who had little knowledge of the ...
(Date:1/20/2017)... ... , ... “Code Word: Chocolate Biscuit”: a biographical account following a man who went on to ... published author, Marlyn Ivey, born in Lynn Haven, Florida and at the age of 5, ... years of age, he joined the Navy and got married right out of boot camp. ...
(Date:1/20/2017)... , ... January 20, 2017 , ... ... ® Oscillating Positive Expiratory Pressure (OPEP) device, was featured in a study indicating ... Pursley, MEd, RRT-ACCS, FAARC, “Analysis of Three Oscillating Positive Expiratory Pressure Devices ...
(Date:1/20/2017)... ... ... “Journey to Christmas:” a beautiful and enchanting tale that teaches children the true meaning of ... three in Oklahoma City, and a devoted woman of faith. , “Becoming a parent ... the back of my mind for years, but actually doing it might have been a ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017 Conference Call and Webcast to ... ) today announced it will release results for the fourth quarter ... ... host a conference call at 4:30 PM ET on Wednesday, February ... full year 2016 financial results and other corporate activities. To participate ...
(Date:1/19/2017)... , Jan. 19, 2017 This report ... current and future scenario of the global market. Large ... opioid consumption. Severe chronic constipation is a major side ... traditional laxatives. Hence, novel targeted therapy has been prescribed ... sufferers, launch of targeted medicines, and growing awareness about ...
(Date:1/19/2017)...  Stealth BioTherapeutics Inc. ( Stealth ), a clinical-stage ... announced new additions to its senior leadership team: ... and Daniel Geffken as interim Chief Financial ... , Pharm.D. has been promoted to Chief Clinical Development ... Doug and Daniel to our management team, as both ...
Breaking Medicine Technology: